Skip to main content
. Author manuscript; available in PMC: 2021 Aug 6.
Published in final edited form as: Catheter Cardiovasc Interv. 2020 May 30;97(6):1129–1138. doi: 10.1002/ccd.29003

Table 3:

In-hospital mortality, cost and LOS in Acute limb ischemia

Acute Limb Ischemia
In-Hospital mortality Length of Stay (in days) ** Cost of Hospitalization (in dollars)
With acute limb ischemia No./Total (%) Without acute limb ischemia No./Total (%) p-value Adjusted Odds Ratio* P-value With acute limb ischemia No./Total (%) Without acute limb ischemia No./Total (%) p-value With acute limb ischemia No./Total (%) Without acute limb ischemia No./Total (%) p-value
Cardiogenic Shock with STMI 585/1628 (35.9%) 51464/17086 3 (30.1%) <0.001 1.21 (1.09–1.36) <0.001 19 11 <0.001 261,168 144,218 <0.001
CS with STEMI without MCS 264/631 (41.8%) 27198/80388 (33.8%) <0.001 1.49 (1.25–1.77) <0.001 19 9 <0.001 197,195 105,985 <0.001
CS with STEMI and IABP 232/805 (28.8%) 22143/85990 (25.8%) 0.04 0.96 (0.81–1.13) 0.63 18 11 <0.001 253,738 166,908 <0.001
CS with STEMI and PVAD 25/74 (33.8%) 828/2004 (41.3%) 0.19 0.30 (0.16–0.56) <0.001 15 15 0.92 292,310 307,405 0.16
CS with STEMI and ECMO 19/33 (57.6%) 229/411 (55.7%) 0.83 1.25 (0.48–3.24) 0.64 30 26 0.32 619,830 498,420 0.08
*

Adjusted for age, sex, race, smoking status, dyslipidemia, alcohol abuse, congestive heart failure, liver disease, peripheral vascular disease, deficiency anemia, chronic pulmonary disease, coagulopathy, renal failure diabetes, hypertension, cardiac arrest and vasopressor use.

**

included all patients that survived the index admission.